| Marc E Arnush, MD, MPH | |
|
9601 S Sepulveda Blvd, Los Angeles, CA 90045-5203 | |
| (310) 215-6020 | |
| Not Available |
| Full Name | Marc E Arnush |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 9601 S Sepulveda Blvd, Los Angeles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114125846 | NPI | - | NPPES |
| A90486 | Other | CA | MEDICAL LIC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | A90486 (California) | Primary |
| 208D00000X | General Practice | A90486 (California) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Marc E Arnush, MD, MPH 9601 S Sepulveda Blvd, Los Angeles, CA 90045-5203 Ph: (310) 215-6020 | Marc E Arnush, MD, MPH 9601 S Sepulveda Blvd, Los Angeles, CA 90045-5203 Ph: (310) 215-6020 |
News Archive
World Vision is preparing to respond to the massive 8.8 magnitude earthquake that hit Chile, working with its regional offices to transport emergency relief supplies and getting ready to send more staff to support the relief response.
Of all the licensing exams along the way to becoming an M.D., the Step 1 is notorious for having the worst national passage rate. By adopting a fully integrated medical curriculum in lieu of the traditional academic model, the University of Texas Medical Branch has seen a dramatic drop over the course of a decade in the failure rate, with underrepresented minority students benefiting the most, according to new research that will be presented April 30, 2010 at the annual meeting of the American Educational Research Association.
Researchers have reported a new material, pliable enough to be woven into fabric but imbued with sensing capabilities that can serve as an early warning system for injury or illness.
Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine-based immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data on the Company's novel DermaVir therapeutic vaccine for HIV/AIDS during the XVIII International AIDS Conference this week in Vienna, Austria. DermaVir, the first dendritic cell-targeting topical HIV vaccine candidate, employs nanotechnology to induce multi-faceted and long-lived immune responses capable of eliminating HIV infected cells.
› Verified 2 days ago
Dr. Bernice Boddie Jackson, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 241 N. Figueroa St., Los Angeles, CA 90012 Phone: 213-989-7168 | |
Dr. Emery Jakab, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 313 N Figueroa St, Los Angeles, CA 90012 Phone: 213-240-8117 | |
Mercy Kagoda, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-648-1229 | |
Susan Bradshaw, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 6320 W Howard Drollinger Way Ste 203, Los Angeles, CA 90045 Phone: 310-665-0300 Fax: 310-665-0303 | |
Dr. Douglas M Frye, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 S Commonwealth Ave Ste 1920, Los Angeles, CA 90005 Phone: 213-351-8196 | |
Dr. Keith Allen Emmons, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 865 Comstock Ave, Unit 3b, Los Angeles, CA 90024 Phone: 818-512-5575 Fax: 310-275-0832 |